Conventional DMARD therapy (methotrexate‐sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: A real‐life experience
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2012 |
---|---|
Erschienen: |
2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
APLAR journal of rheumatology - 15(2012), 6 vom: Dez., Seite 526-530 |
Beteiligte Personen: |
Can, Meryem [VerfasserIn] |
---|
Umfang: |
5 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1909279013 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1909279013 | ||
003 | DE-627 | ||
005 | 20230515190604.0 | ||
007 | tu | ||
008 | 121220s2012 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a sw121219_1 |
035 | |a (DE-627)OLC1909279013 | ||
035 | |a (DE-599)GBVOLC1909279013 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 610 |
100 | 1 | |a Can, Meryem |e verfasserin |4 aut | |
245 | 1 | 0 | |a Conventional DMARD therapy (methotrexate‐sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: A real‐life experience |
264 | 1 | |c 2012 | |
300 | |a 5 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Aydın, Sibel Z. |4 oth | |
700 | 1 | |a Niğdelioğlu, Adil |4 oth | |
700 | 1 | |a Atagündüz, Pamir |4 oth | |
700 | 1 | |a Direskeneli, Haner |4 oth | |
773 | 0 | 8 | |i Enthalten in |a Asia Pacific League of Associations for Rheumatology ; ID: gnd/10045994-8 |t APLAR journal of rheumatology |d Carlton : Blackwell Publ. Asia, 1998 |g 15(2012), 6 vom: Dez., Seite 526-530 |w (DE-627)484837168 |w (DE-600)2185795-7 |x 0219-0494 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2012 |g number:6 |g month:12 |g pages:526-530 |g extent:5 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
951 | |a AR | ||
952 | |d 15 |j 2012 |e 6 |c 12 |h 526-530 |g 5 |